Biological Transporters as Targets for New Drug Design

Hui Po Wang, Chun Li Wang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The biological system, which forms the basis for drug-host, drug-food, and drug-drug interactions, is full of mechanisms designed to manipulate drug action. These mechanisms, namely absorption, distribution, metabolism, and excretion (ADME), thus become targets in pharmaceutical research for optimizing the pharmacodynamic/pharmacokinetic profiles of drugs. The body system is also full of resources, such as transporters, for designing new chemical entities as therapeutic agents. This review highlights current research in using biological transporters as a proactive approach in drug delivery to optimize efficacy in the early stages of drug development, and as a target for rational design of prodrugs as novel therapeutic agents. The structural design of prodrugs using delivery moieties such as D-phenylglycine for improving intestinal absorption of levodopa is presented as an example.

Original languageEnglish
Pages (from-to)31-38
Number of pages8
JournalJournal of Experimental and Clinical Medicine(Taiwan)
Volume1
Issue number1
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Drug Design
Pharmaceutical Preparations
Prodrugs
Intestinal Absorption
Levodopa
Drug Interactions
Pharmacokinetics
Food
Therapeutics
Research

Keywords

  • ADME
  • delivery system
  • PEPT1
  • prodrug
  • transporter

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Biological Transporters as Targets for New Drug Design. / Wang, Hui Po; Wang, Chun Li.

In: Journal of Experimental and Clinical Medicine(Taiwan), Vol. 1, No. 1, 12.2009, p. 31-38.

Research output: Contribution to journalArticle

Wang, Hui Po ; Wang, Chun Li. / Biological Transporters as Targets for New Drug Design. In: Journal of Experimental and Clinical Medicine(Taiwan). 2009 ; Vol. 1, No. 1. pp. 31-38.
@article{992e3bcb2bf2498598a0b4578cbfb53e,
title = "Biological Transporters as Targets for New Drug Design",
abstract = "The biological system, which forms the basis for drug-host, drug-food, and drug-drug interactions, is full of mechanisms designed to manipulate drug action. These mechanisms, namely absorption, distribution, metabolism, and excretion (ADME), thus become targets in pharmaceutical research for optimizing the pharmacodynamic/pharmacokinetic profiles of drugs. The body system is also full of resources, such as transporters, for designing new chemical entities as therapeutic agents. This review highlights current research in using biological transporters as a proactive approach in drug delivery to optimize efficacy in the early stages of drug development, and as a target for rational design of prodrugs as novel therapeutic agents. The structural design of prodrugs using delivery moieties such as D-phenylglycine for improving intestinal absorption of levodopa is presented as an example.",
keywords = "ADME, delivery system, PEPT1, prodrug, transporter",
author = "Wang, {Hui Po} and Wang, {Chun Li}",
year = "2009",
month = "12",
doi = "10.1016/S1878-3317(09)60008-5",
language = "English",
volume = "1",
pages = "31--38",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "1",

}

TY - JOUR

T1 - Biological Transporters as Targets for New Drug Design

AU - Wang, Hui Po

AU - Wang, Chun Li

PY - 2009/12

Y1 - 2009/12

N2 - The biological system, which forms the basis for drug-host, drug-food, and drug-drug interactions, is full of mechanisms designed to manipulate drug action. These mechanisms, namely absorption, distribution, metabolism, and excretion (ADME), thus become targets in pharmaceutical research for optimizing the pharmacodynamic/pharmacokinetic profiles of drugs. The body system is also full of resources, such as transporters, for designing new chemical entities as therapeutic agents. This review highlights current research in using biological transporters as a proactive approach in drug delivery to optimize efficacy in the early stages of drug development, and as a target for rational design of prodrugs as novel therapeutic agents. The structural design of prodrugs using delivery moieties such as D-phenylglycine for improving intestinal absorption of levodopa is presented as an example.

AB - The biological system, which forms the basis for drug-host, drug-food, and drug-drug interactions, is full of mechanisms designed to manipulate drug action. These mechanisms, namely absorption, distribution, metabolism, and excretion (ADME), thus become targets in pharmaceutical research for optimizing the pharmacodynamic/pharmacokinetic profiles of drugs. The body system is also full of resources, such as transporters, for designing new chemical entities as therapeutic agents. This review highlights current research in using biological transporters as a proactive approach in drug delivery to optimize efficacy in the early stages of drug development, and as a target for rational design of prodrugs as novel therapeutic agents. The structural design of prodrugs using delivery moieties such as D-phenylglycine for improving intestinal absorption of levodopa is presented as an example.

KW - ADME

KW - delivery system

KW - PEPT1

KW - prodrug

KW - transporter

UR - http://www.scopus.com/inward/record.url?scp=77949286408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949286408&partnerID=8YFLogxK

U2 - 10.1016/S1878-3317(09)60008-5

DO - 10.1016/S1878-3317(09)60008-5

M3 - Article

AN - SCOPUS:77949286408

VL - 1

SP - 31

EP - 38

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 1

ER -